BRIEF published on 04/21/2026 at 20:35, 5 days 12 hours ago Adocia Reports 2025 Financial Results and Strategic Developments Corporate Governance Financial Results 2025 Biopharmaceutical Advancements BioChaperone® Technology Partnerships And Patents
PRESS RELEASE published on 04/21/2026 at 20:30, 5 days 12 hours ago Inside Information / News release on accounts, results ADOCIA announces full year 2025 financial results, highlights positive Phase 3 results for diabetes treatment, and secures cash runway until Q2 2027. Company advancements in key technology platforms showcased Financial Results Diabetes Treatment Phase 3 Results ADOCIA Technology Platforms
BRIEF published on 04/21/2026 at 19:35, 5 days 13 hours ago ADOCIA concludes a financial agreement with Vester Finance Treasury Funding Biopharmaceutical ADOCIA Vester Finance
BRIEF published on 04/21/2026 at 19:35, 5 days 13 hours ago ADOCIA Secures €6 Million Shareholder Loan from Vester Finance Shareholder Loan Cash Runway ADOCIA BioChaperone® Vester Finance
PRESS RELEASE published on 04/21/2026 at 19:30, 5 days 13 hours ago Inside Information / Other news releases Adocia secures €6.0 million shareholder loan from Vester Finance, extending cash runway until Q2 2027. Funds for BioChaperone and AdoXLong development Shareholder Loan ADOCIA Vester Finance Cash Runway Extension BioChaperone
BRIEF published on 12/08/2025 at 19:35, 4 months 18 days ago ADOCIA Announces Share and Voting Rights Update Voting Rights Shares Financial Disclosure Diabetes Treatment ADOCIA
PRESS RELEASE published on 12/08/2025 at 19:30, 4 months 18 days ago Inside Information / Other news releases Adocia SA releases total number of shares and voting rights as of December 8th, 2025. Company focuses on innovative therapeutic solutions for diabetes and obesity Voting Rights Shares Diabetes Obesity ADOCIA
BRIEF published on 12/04/2025 at 07:35, 4 months 23 days ago ADOCIA Secures €10 Million Fundraising for Growth Shares Fundraising Investment Biopharmaceutical ADOCIA
PRESS RELEASE published on 12/04/2025 at 07:30, 4 months 23 days ago Inside Information / Other news releases Adocia successfully completes a €10 million fundraising through a capital increase. Proceeds to support technology platform development. Cash runway extended to 2027 Fundraising Capital Increase Cash Runway ADOCIA Technology Platforms
BRIEF published on 11/12/2025 at 07:35, 5 months 15 days ago Adocia Progresse with AdoXLongTM and BioChaperone® Diabetes Patent ADOCIA BioChaperone® AdoXLongTM
Published on 04/25/2026 at 03:10, 2 days 6 hours ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 2 days 11 hours ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:00, 2 days 11 hours ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 2 days 18 hours ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 2 days 18 hours ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/27/2026 at 09:05, 17 minutes ago OneLayer Launches Sentry Partner Program to Extend Zero Trust Security for Private Cellular Networks
Published on 04/27/2026 at 09:00, 22 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 04/27/2026 at 09:00, 22 minutes ago Original-Research: GFT Technologies SE (von NuWays AG): BUY
Published on 04/27/2026 at 09:00, 22 minutes ago Original-Research: ATOSS Software SE (von NuWays AG): BUY
Published on 04/24/2026 at 17:45, 2 days 15 hours ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 2 days 16 hours ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 3 days 13 hours ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 3 days 15 hours ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
